Your breathing pattern is unique like your fingerprint—and may help predict health issues
In a new study, scientists identified people based only on their breathing pattern with almost 97 percent accuracy—and soon might be able to analyze yours to diagnose what ails you. Colored 3D computed tomography (CT) scan of the spaces within the facial bones surrounding the nasal cavity. Illustration by Vsevolod Zviryk, Science Photo Library
Everyone's breathing pattern is unique, and soon scientists might be able to analyze yours to diagnose what ails you.
Scientists were able to identify individual people based just on their breathing pattern with 96.8 percent accuracy, and different patterns corresponded to differences in physical and mental traits, according to a new study in Current Biology.
Because it happens subconsciously, breathing may seem simple, but it's controlled by a complex brain network.
'Respiration has to be coordinated with almost everything,' says Noam Sobel, neurobiologist at the Weizmann Institute of Science in Israel and co-author of the new study. From timing our breathing when we speak, to when we swim, the respiratory system is often negotiating with various parts of the brain.
'Although breathing starts with this breathing center in the brain stem, it actually ends up being coordinated with a humongous chunk of your brain,' says Sobel. Those different parts of the brain include regions responsible for language, emotion, and motor skills.
Inhaling drives specific waves in the brain's memory center that help consolidate memories. When we inhale, pressure in the nasal cavity changes, which excites neurons that send signals to the brain, according to Detlef Heck, a University of Minnesota neuroscientist who was not involved with the new research.
The moment of transition from breathing out to breathing in might have a sort of reset effect in the brain, so changing the breath can help stress regulation and cognitive performance. Slow breathing techniques are used to reduce stress and anxiety, alter mood, and changing breathing patterns can affect cognitive ability and focus.
Scientists are still learning about how the brain shapes breath, how breath shapes the brain, and what information this could one day tell doctors about a patient's health. Unique breath 'fingerprints'
The team conducting the new research mostly studies the brain-breath connection in olfaction, or how taking in scents through the nose brings information directly to the brain to process.
Since every brain is unique, the study authors hypothesized that the respiratory patterns shaped by those brains would also be unique.
To test their hypothesis, the team developed a lightweight, wearable tube that fit inside the participant's nose and continuously tracked nasal airflow over 24 hours. A hundred healthy young adults wore the nasal tube device while going about their daily lives, and logged their activities in a cell phone app.
Study participants all had remarkably distinct breathing patterns, according to the results. The research team was able to identify individuals from only their breathing patterns with 96.8 percent accuracy using a machine learning analysis. This level of accuracy was consistent across multiple retests over two years, meaning the test's precision rivals that of some voice recognition technologies.
'It's very rare that you can predict a biological process so accurately,' says Sobel.
Each respiratory 'fingerprint' also provided insights into each person's mental and physical condition, since certain breathing patterns correlated with body mass index, sleep-wake cycle, and depression and anxiety. Participants who had higher anxiety levels based on questionnaire responses, for example, tended to have shorter inhales and more varied pauses between breaths while sleeping.
Pauses between breaths turned out to be an especially meaningful parameter: one person might consistently pause for one second after each breath, while another person might sometimes pause for one second and other times pause for five seconds. This variability statistic was a powerful tool in the predictive models, says Sobel.
Nasal airflow is so closely connected to the brain because of the evolution of the sense of smell, scientists theorize.
Nasal breathing has also been linked to how we form mental images, for example, and smell is associated with how we store memories.
That may be because smell is the oldest sensory system to exist in mammals, says Sobel, and it's considered a sort of evolutionary scaffolding organizing the evolution of the structure of the mammalian brain.
Although modern humans are more visually-oriented, connections between nasal breathing and so many parts of the brain could be a mechanism left over from evolution, explains Daniel Kluger, neuroscientist at the University of Münster in Germany, who was not involved with the new research.
In studies on performance in visual and spatial tasks—having nothing to do with smell—people tend to perform better while inhaling than while exhaling. This could be because inhalation makes us more sensitive toward any sensory inputs, not only smell, says Kluger, so we're more likely to perceive visual, auditory, and tactile information when it's presented while we're breathing in.
'You're in a particular bodily state [while inhaling] that makes you more sensitive to incoming sensory stimuli,' explains Kluger. Change your breath to change your brain?
Measuring the link between breathing patterns and health conditions on more people could help develop breath analysis as a diagnostic tool, say scientists.
'This is a super exciting finding, but someone needs to show it also works for other [groups],' says Heck, 'but in general I think this is a very promising direction.'
The study authors are now testing their device and analysis method to screen for diseases.
The findings also raise questions about whether changing breath patterns could change what's going on in the brain.
'There's a chicken and egg question here, of what drove what: are you breathing this way because you're depressed, or are you depressed because you breathe this way?' asks Sobel. 'If it's the latter, then that's potentially exciting because that opens paths to intervention—so, can I teach you to breathe in a way that will make you less depressed or less anxious?'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
2 days ago
- UPI
Israeli PM Netanyahu calls Iran 'evil' as he tours site of missile strike
1 of 6 | Calling Iran an 'evil regime,' Israeli Prime Minister Benjamin Netanyahu on Friday visited the Weizmann Institute of Science, close to where an Iranian missile hit earlier this week. Pool Photo by Jack GUEZ/UPI | License Photo June 20 (UPI) -- Calling Iran an "evil regime," Israeli Prime Minister Benjamin Netanyahu on Friday visited the Weizmann Institute of Science, close to where an Iranian missile hit earlier this week. "This is the world-renowned Weizmann Institute, where the most advanced research in human biology is conducted -- medical research, genetic research," Netanyahu told reporters during the tour of the institute in the city of Rehovot in central Israel, some 12.5 miles south of Tel Aviv with a population of 150,000 people. "This research was shattered by a missile from the evil regime. They seek to destroy human progress. That is the essence of this regime. They have enslaved and oppressed their people for nearly 50 years -- half a century. Iran is the leading terrorist regime in the world. It must not be allowed to possess nuclear weapons. This is Israel's mission: to save itself from the Iranian threat of annihilation. In doing so, we are saving many, many others." Netanyahu's tour of the site where two buildings were completely destroyed came a day after the prime minister said in a post on X, "We will make the tyrants from Tehran pay the full price." Iranian missile strikes also hit the largest hospital in Southern Israel earlier in the week. The two countries are engaged in hostilities over Iran's nuclear program. The Weizmann Institute is known as the research crown jewel of Israeli science, with laboratories dedicated to studying health issues such as cancer, heart disease and neurodevelopmental disorders. "It's completely gone. Not a trace. Nothing can be saved," Professor Oren Schuldiner told The Economic Times. Officials estimate the damage from Iranian missiles to the institute at more than $500 million. Thousands of hours of research have also been lost. "The most valuable resource of the Weizmann Institute, aside from property, are samples that have been stored for decades in labs for scientific research -- and all of it is gone, with no backup," Biomolecular Sciences Department Professor Tslil Ast told Y Net News. Netanyah also toured an Israel Defense Forces base Friday where he praised intelligence officers for their work in the recent operations carried out in Iran. "I am here at an IDF Intelligence base with the head of IDF intelligence, and with our amazing people, the soldiers, both conscripts and reservists, who are doing sacred work in providing us with the intelligence that wins wars," Netanyahu said, accompanied by Strategic Affairs Minister Ron Dermer, National Security Council Director Tzachi Hanegbi and other top officials. "I cannot exaggerate the importance of the work that has been done, and which is being done at the moment, in achieving the total victory. Head of IDF Intelligence, thank you very much. For myself, the citizens of Israel and the Government of Israel, please convey my gratitude to everyone." Tensions in the region continue to escalate, with representatives from the European Union and Britain meeting for ciris talks on Friday with the Iranian counterparts. U.S. President Donald Trump on Thursday set a 14-day deadline to decide on possible American military involvement in the Israel-Iran conflict. On Friday, French Foreign Minister Jean-Noel Barrot said the goal of Western allies is "obtaining from Iran a lasting rollback of its nuclear and ballistic missiles programs."
National Geographic
2 days ago
- National Geographic
Statin drugs are an Internet villain. Do they deserve it?
Cholesterol-lowering medicines are some of the most commonly prescribed, effective drugs. Influencers on TikTok have other ideas. The cholesterol-lowering drug Simvastatin. Like other statins, this drug reduces the levels of low-density lipoprotein (LDL) cholesterol in the body. Over 40 million Americans currently take statins. Photograph by James King-Holmes, Science Photo Library Inside the average doctor's office, statins aren't controversial; they're a crucial lifesaving tool used to lower dangerously high cholesterol levels, reducing risk of heart attack. But on social media, the drug is often villainized, painted as a poison pill, or a symptom of a diseased medical system. Recently, influencers have claimed that statins cause more harm than good and have endless side effects. Others take even bigger swings, claiming that the fundamental science behind cholesterol is a myth, one that's used simply to sell more statins . 'If you only went online,' Spencer Nadolsky says, 'you would never want to have a statin.' Nadolsky, a physician who specializes in obesity and lipids, is familiar with the social media critiques. 'It's one of the most fear-mongered yet amazing drugs of our time,' he says. How did boring generic pharmaceutical—a drug prescribed to 200 million people worldwide—become controversial? Part of the answer is influencers who proselytize ketogenic and carnivore diets, promising weight loss and other health benefits through the consumption of high fat consumption and limited carbohydrates. When adhering to one of these diets, the body uses fat as its main fuel source instead of carbohydrates, which can lead to loss of body fat while maintaining muscle mass. The success of these diets is often bolstered by fit social media influencers eating red meat off a cutting board, touting the benefits of their preferred version of a low-carbohydrate, high-fat diet. One influencer even claimed that her transition from a vegan diet to a carnivore diet cured her of everything from brain fog to flatulence. But keto and carnivore have been associated with dramatic increases in low density lipoprotein (LDL) cholesterol—the cholesterol most strongly associated with heart disease, often called the 'bad' cholesterol. Rejecting the lipid hypothesis, many influencers cast doubt on the widely accepted concept that cholesterol contributes to atherosclerosis, which is the buildup of fats and cholesterol in and on the artery walls. The head of a 60 year old patient with high blood pressure and high blood cholesterol. The blood vessels are the result of atherosclerosis which is the buildup of fats and cholesterol in and on the artery walls. Image by Zephyr/Science Photo Library Clinical lipidologist Tom Dayspring describes claims like these as 'ketogenic nonsense.' He says that patients might not experience any symptoms of atherosclerosis until it's too late. What some people don't understand, Dayspring explains, is that heart disease only presents symptoms like chest pain and arrhythmia in very late stages of progression. Symptoms, Dayspring notes, can't be used to diagnosis the disease. 'Most people are dropping dead before they get any symptoms of heart disease,' he says. A scent, a touch, or a sip can be just what you need to lock an important moment into your mind forever. Dayspring says that LDL levels in the United States follow a bell curve. In general, doctors want to get their patients to the 20th percentile or lower, or around 100 mg of LDL cholesterol per deciliter of blood. Once you go above the 20th percentile, the exponential risk becomes a 'straight line to heaven,' Dayspring says. The only way to reduce serious medical issues like heart attacks, heart failure, and strokes brought on by plaque accumulation in the arteries is to achieve very low levels of LDL cholesterol. Dayspring describes it as 'an illegal dump job of cholesterol in your artery wall.' A lipid can only travel through plasma when it's wrapped in a protein known as a lipoprotein. 'Some lipoproteins, for whatever reason, leave plasma, crash the artery wall, and dump their cholesterol.' That's where statins can help. Low-density lipoproteins, or LDLs, are molecules that are a combination of fat and protein and are the form in which lipids are transported in the blood. LDLs transport cholesterol from the liver to the tissues of the body, including the arteries, which has lead LDL being known as "bad" cholesterol. Micrograph by Science Photo Library A colored transmission electron micrograph of high density lipoprotein (HDL), or 'good' cholesterol. HDL cholesterol plays a role in fat metabolism and contributes to cardiovascular health Micrograph by Lennart Nilsson, TT/Science Photo Library Approved in the United States in 1987, statins work by blocking an enzyme in the liver—where most of the body's cholesterol is produced—which prevents LDL production. Statins reduce the risk of heart attack, stroke, and heart disease, which is still the leading cause of death in the United States. Over 40 million Americans currently take statins. Until the early 2000s, statins were the only game in town for managing cholesterol, Dayspring says. Now, there are newer drugs that can also help. One class of drugs, PCSK9 inhibitors, lowers LDL cholesterol by blocking the protein that binds to LDL receptors, keeping these receptors available to clear LDL cholesterol from the blood stream. Unlike statins, these drugs haven't been vilified by. While LDL is often referred to as the 'bad' cholesterol because it can contribute to plaques, and HDL is called the 'good' cholesterol for clearing excess cholesterol from the arteries, it's not black and white. The body requires LDL to function since it assists in cellular construction and repair and serves as a building block for many essential hormones. 'I tell patients up front, [LDL] is the delivery cholesterol, because every tissue in your body needs tens of thousands of doses of cholesterol every day,' says Stephen Kopecky, a preventative cardiologist and the director of the Mayo Clinic's Statin Intolerance Clinic in Minnesota. 'If you didn't have it, you'd be dead,' Kopecky explains. 'So it can't be that bad. There's a sweet spot.' But LDL is just one measure of cholesterol. Dayspring thinks the most measurement to pay attention to is apolipoprotein B, or ApoB, the protein component found in several lipids, including LDL, but not HDL. ApoB, involved in cholesterol transport, is considered superior to LDL cholesterol to assess the risk of heart disease. Unlike LDL cholesterol, ApoB captures a more complete picture of all potentially plaque-causing particles in the blood. For example, a person with normal LDL cholesterol but high ApoB would still be at risk for heart disease. Looking at ApoB is relatively new in the United States, which has historically used LDL. But the rest of the world uses this measurement, says Kopecky. Statin side effects and intolerance Like all medication, statins have side effects. On social media, these side effects are often front-and-center, used by influencers to show that the drug is inefficient or steer followers from considering the medication altogether. The most common are muscle aches, headaches, digestive issues. More seriously, for people with insulin resistance, there's an increased risk to develop Type 2 diabetes (though the American Diabetes Association advises that people with diabetes go on a statin if they're older than 40). To Nadolsky, the benefits outweigh the risks. He compares taking statin to taking daily multivitamin. In his practice, he's able to convince skeptical patients who've bought into the influencer-driven narrative around statins with some basic facts. If the patient claims that LDL cholesterol is not the cause of development of plaque in the arteries, he'll point out that the association is 'one of the most grounded scientific things we know.' Nadolsky's claims are backed up by a trove of evidence, including a 2017 a meta-analysis in the European Heart Journal. That paper found that the totality of evidence 'unequivocally establishes' that LDL causes atherosclerotic cardiovascular disease (ACSVD.) In 2020, the panel restated its conclusion, and also identified emerging evidence for ApoB's role in ASCVD. Some patients, however, are statin intolerant. A 2022 meta-analysis drawing on 4.1 million patients found statin intolerance within 9.1 percent of this population. By Kopecky's estimation, there are three types of statin intolerant patients: those who experience body aches on the medication, and who cycle their use on and off to manage their cholesterol. Kopecky is part of this group. He experiences muscle aches after several months on a statin. Doctors will sometimes temporarily discontinue a patient's statins and then add statins back to their regimen with either modified doses or a different statin to curb side effects. A second group experiences 'these weird symptoms that aren't really related to when they take the medicine.' Researchers have observed a nocebo effect, or negative placebo effect associated with statins, and one 2020 study found this effect might be increasing. The third group, which Kopecky finds most concerning, are those worried about potential statin intolerance, who won't ever visit Kopecky's office. Many patients, he says, will come in and say, 'I don't want to take this drug. I've been on the Internet. I know that's bad for me, doctor.' A statin's effects on the brain are another concern around the medication. Statins are the only drug that can cross the blood-brain barrier and inhibit cholesterol synthesis in the brain, which is the body's most cholesterol-rich organ, Dayspring explains. Cholesterol is required for the brain to operate, but excess cholesterol in the brain can cause neurodegenerative diseases, including Alzheimer's. Dayspring points to the evidence which, he says, shows that 'statins do not hurt the brain in any way, but they actually improve dementia a little bit.' For the exceedingly rare group of people who experience brain fog while on statins, he theorizes that they've over-suppressed the brain's synthesis of cholesterol. But since the brain makes its own cholesterol, drugs that lower cholesterol levels in the liver do not affect the brain's cholesterol levels. Self-guided research on cholesterol and statins can lead to conflicting advice. A quick scan of the best-selling heart health books on Amazon shows titles like The Great Cholesterol Myth and The Cholesterol Hoax, and other offerings that advise readers to load up on red meat, Kopecky says. These books capitalize on a well-established formula. Diet books, Malcolm Gladwell wrote in the New Yorker more than two decades ago, are 'selling something that people want to buy: the idea that they can eat whatever they want.' Beyond misinformation, part of the mistrust around statins is that drug companies didn't initially provide all the information about the drug's side effects, leading doctors, including Kopecky, to pass on incomplete information to patients. It took 20 years before doctors realized that statins can cause a minor increase in blood glucose, which can lead to type 2 diabetes. The lagging response, Kopecky says, has led to some patients to distrust their doctors on this specific treatment. Cholesterol deposits causing the narrowing of a blood vessel which raises blood pressure and puts strain on the heart. Atherosclerosis is the main cause of heart attacks. Photograph by Lennart Nilsson, Boehringer Ingelheim/TT/Science Photo Library Colored coronary angiogram of a 53 year old patient with severe narrowing of the circumflex coronary artery. Photograph by Zephy/Science Photo Library Regardless of claims on the internet, the only lifestyle change that can help control LDL cholesterol is significantly reducing the consumption of saturated fats, Dayspring says. For people with cardiovascular risk that can't be controlled by lifestyle factors, pharmacological intervention is the only option. And the first drug doctors reach for is statins. Lifestyle, Kopecky says, is incredibly important. While a large portion a person's cholesterol is genetic, any positive change is welcome, according to the data. 'Nothing you do to improve your health is ever too little, and nothing you do to improve your health is ever too late in your life,' he says. But he's bearish on keto. 'You just can't eat a keto diet forever,' Kopecky says. There is a healthy version of the diet, he notes—one that relies on extra virgin olive oil, nuts, and avocado oils as the primary fat sources, with just one ounce of red meat per day—but that's a far cry from the steak-loaded cutting boards influencers tout on social media. The carnivore diet often conjures mental images of predators in the wild, consuming double-digit pounds of meat per day. There is even one strict regimen of red meat, salt, and water, is known as the 'Lion Diet.' But despite the image of a diet bridging the gap to our animalistic nature, only humans have high cholesterol, Dayspring notes. 'Things that eat meat all day long, have LDL cholesterols of 15 to 20.' One criticism of statins is that they're overprescribed. And a recent study published in JAMA Internal Medicine found that's likely the case, but it didn't question the benefits of statins or their necessity. According to the study, '50 million US adults aged 40 years and older meet criteria for elevated ASCVD risk,' for a statin prescription, even by the study's revised numbers. To convince wary patients, Nadolsky shares a personal datapoint: he's on a statin. 'I practice what I preach,' he says. Statins are one of the best medicines in use, according to Nadolsky. 'It's just a shame that people aren't utilizing them, due to the fear mongering that is done online.' A 2019 study published in JAMA Cardiology showed less adherence to taking statin medication was associated with more incidences of death for patients with ASCVD. Kopecky, too, is concerned with patients who explicitly say they don't want to take statins after reading about them on the internet. In response, his clinic polled 1,200 of these patients to see what would tip the scales to change their minds about statins. The patients wanted to know three things: cholesterol is involved in heart disease, doctors have a way to lower risk of heart disease, and the treatment is safe. As a result, Kopecky and the Mayo Clinic released a series of videos to address each of these three points. Still, medical misinformation still runs rampant on social media and even crops up next to reputable professionals on social media. When viewing a YouTube video of Kopecky discussing statin misinformation on Mayo Clinic Radio, two of the recommended videos in the sidebar were a video purporting to reveal the 'big pharma' conspiracy behind statins and a second one claiming that LDL cholesterol is a myth. 'LDL is not a myth, and you have to look at the totality of evidence,' Kopecky says. He thinks anyone with high cholesterol should seek treatment for it but understands they might not want to: 'You can't make everybody drink the Kool-Aid.'
Yahoo
3 days ago
- Yahoo
'Shocking' find could change the way Aussies visit the beach
For 200 years, there has been speculation that swimmers could be tormented by more than one species of bluebottle jellyfish. It turns out there are at least four, including one in Australia that has a 'prominent nose'. 'We were shocked, because we assumed they were all the same species," Griffith University marine ecologist Professor Kylie Pitt said. Until recently, studying these notorious jellyfish has been a challenge because they're hard to keep in captivity, and when they wash up on the beach they disintegrate quickly. Speaking with Yahoo News, Pitt explained the game-changer has been advances in DNA sequencing. 'With our paper, we used the most powerful method, whole genome sequencing, so it's entire DNA has been sampled,' she said. 'By combining the DNA with morphology, we've got the strongest evidence possible for separating out the species.' The discovery is likely to have a direct impact on Aussie swimmers because it could help researchers better understand jellyfish behaviour and predict when they'll swarm towards beaches. Pitt was part of an international research effort by Yale University, University of New South Wales and Griffith University that sequenced the genomes of 151 jellyfish from around the world and published their findings in the journal Current Biology. A key finding of the study that the notorious Portuguese man o' war is only found in the Atlantic and is a completely separate species from Australian bluebottles. 'For a long time, people have said they're much bigger over there and the venom is much more potent,' Pitt said. 'Now we know that the potency of their venom might differ.' Related: 😳 Swimmer's painful encounter with deadly creature on Queensland island The existence of three newly described species, Physalia physalis, Physalia utriculus and Physalia megalista, had been proposed in the 18th and 19th Centuries, but the idea was later dismissed. The researchers also identified a fourth species Physalia minuta that had never been described before. 'The one that really stands out is Physalia megalista because it has a really pronounced nose,' Pitt said. It's also believed there are several distinct subpopulations shaped by regional winds and ocean currents. This new knowledge about bluebottles will have a real-world impact for swimmers, as there could be differences with the venom of Australian species too. It will also help support an investigation into jellyfish behaviour that's funded by the Australian Research Council. 🌏 Secret hidden beneath Australia's 'most important' parcel of land 👙 Tourists oblivious to disturbing scene 500m off sunny Aussie beach 📸 Confronting picture showcases state of Aussie wildlife on world stage Pitt explained a PhD student is working to understand how winds and currents move the bluebottles towards beaches, as well as how they move in the water. 'Bluebottles can actually erect their float or lay it down, depending upon what the wind conditions are. And they can also expand and or extend and contract their tentacles, which might act a little bit like a sea anchor, so there might be a bit more of a drag,' she said. 'Now we know there are at least three species in Australia she may need to look at their behavioural differences.' Love Australia's weird and wonderful environment? 🐊🦘😳 Get our new newsletter showcasing the week's best stories.
